Serve’s key risk is not whether robots can move; it is whether the company can keep enough of the economics after platform partners, regulators, support costs, and future
dilution take their share. The core proof points remain revenue per robot, recurring software mix, hospital expansion quality, and whether new capital is raised faster than durable gross profit is created.